Managed Care
Disease
Management

Apremilast Offers a Strong Oral Choice for Psoriatic Arthritis Patients

Kenneth Gordon, Professor of Dermatology at Northwestern University, talks about the oral medication apremilast, recently approved for psoriatic arthritis. Apremilast offers a major benefit to patients — especially those who don’t want an injectable medication. Its response rates are high and it is very well tolerated.

Meetings

HealthIMPACT Southeast Tampa, FL January 23, 2015